BI, Lilly hook up to test breast cancer combo
Boehringer Ingelheim and Lilly are teaming up again, this time to test the potent of a novel combination of two medicines for the treatment of breast cancer.
Read More
Tag: BI 836845
- European life sciences coalition launched to boost investment ecosystem
- 99mtc‑maraciclatide granted fast track status for ILD imaging
- Bioxytran reports rapid viral clearance in phase 2 trial
- Thx Pharma and Biocodex sign rare disease licensing deal
- AstraZeneca bladder cancer therapy wins NICE backing
